在中子捕获中增加细胞杀伤效应,增强质子束疗法
Shintaro Shiba1,2,3, Takahiro Shimo4, Masashi Yamanaka4
1Department of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1, Okamoto, Kamakura, Kanagawa, 247-8533, Japan. shiba4885@yahoo.co.jp.
Scientific reports
|November 18, 2024
概括
中子捕获增强质子束疗法 (NCEPBT) 增加了对各种癌细胞的细胞杀伤效应. 在NCEPBT中的较高度显著提高了其有效性,对临床应用有希望.
科学领域:
- 在瘤学瘤学.
- 医学物理 医学物理
- 辐射疗法 辐射疗法
背景情况:
- 质子束疗法 (PBT) 产生热中子.
- 对于增强的PBT (NCEPBT),建议使用进行中子捕获反应.
- 需要进一步调查NCEPBT的细胞杀伤效应.
研究的目的:
- 为了评估NCEPBT的细胞杀伤效果.
- 为了确定度对NCEPBT疗效的影响.
- 评估NCEPBT的相对生物有效性 (RBE).
主要方法:
- 蒙特卡洛模拟以建模中子分布.
- 用X射线,PBT和NCEPBT对人类癌细胞系 (HSG,MG63,SAS,G-361) 进行辐射.
- 在NCEPBT期间波罗基氨酸度 (20和80 ppm) 的变化.
主要成果:
- 来自PBT的中子在模拟中均分布.
- 与单独使用PBT相比,使用80ppm的NCEPBT在所有测试细胞系中显示出明显更高的RBE值.
- 随着的度增加,RBE值增加,这表明细胞杀死增强.
结论:
- NCEPBT表明细胞杀死效果增加,特别是在较高度的中.
- 这些发现支持NCEPBT的临床潜力.
- 对NCEPBT的进一步研究对于其临床应用是有必要的.
相关概念视频
Nuclear Transmutation
17.4K
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
17.4K
Nuclear Overhauser Enhancement (NOE)
641
Irradiation of a spin-active nucleus causes an increase or decrease in the signal intensity of neighboring nuclei that are not necessarily chemically bonded or involved in J-coupling. This phenomenon, called the Nuclear Overhauser Enhancement (NOE), results from through-space interactions between the nuclear spins. The NOE effect decreases with increasing internuclear distance and is generally not observed beyond 4 angstroms. In NOE, dipole-dipole interactions between neighboring...
641
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


